Story perspectives
Genomic Sequencing Revolutionizes Cancer Treatment in Hong Kong
12/27/2025
1 of 1
Story summary
- Aya El Helali, a clinician-scientist at the University of Hong Kong, says genomic sequencing enhances cancer treatment.
- El Helali says the city could serve as a vital link between mainland China and global drug development.
- El Helali notes that collaboration in the Greater Bay Area speeds trials and attracts pharmaceutical companies.
- El Helali notes that sequencing shortened the time to identify brain cancer treatments from five-to-ten years to one-to-two years.
